$1.410
+0.041 (+2.92%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
PRQR Prediction & Forecast by Similar Chart Analysis
Alphio's PRQR stock price prediction model matches the current ProQR Therapeutics NV tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.42 (+0.59%). The 1-week path is $1.41 (+0.34%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy ProQR Therapeutics NV Stock?
ProQR Therapeutics is currently trading at $1.32, significantly below its 52-week high of $2.65, indicating potential upside. However, the stock has a low RSI of 39.15, suggesting it is nearing oversold territory, but it also reflects weak momentum. The company has a gross margin of 100%, which is excellent, but it has reported consistent net losses, with a net income loss of €13,383,000 in Q1 2026. The main risk is the company's ongoing financial losses and reliance on external financing, as evidenced by a recent direct offering that caused a 20% drop in share price. Given these factors, it may be prudent to hold rather than buy at this time, as the stock may need to stabilize before a clear buying opportunity arises.
PRQR stock price ended at $1.41 on Wednesday, after rising +2.92%
ProQR Therapeutics NV (PRQR) last closed at $1.41, gaining +2.92%. These facts feed the 1-day and 1-week PRQR price prediction above.
Analyst Consensus
ProQR Therapeutics NV (PRQR): 3 buy, 1 hold, 0 sell. Outlook: Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
ProQR Therapeutics NV (PRQR) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches PRQR, ranked by similarity.
Seasonality analysis for PRQR
Historically the probability of a positive November return for PRQR is 46.51%. December offers the highest probability of a positive month at 48.84%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for PRQR
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $1.23 | $2.01 | $2.85 | +42.89% |
| Dec 2026 | $1.58 | $1.82 | $2.08 | +28.77% |
In 2026, ProQR Therapeutics NV (PRQR) is projected to range from $1.23 to $2.85.
ProQR Therapeutics NV 2026 monthly forecast
In Nov 2026, ProQR Therapeutics NV is projected to average $2.01, with a low of $1.23 and high of $2.85.
In Dec 2026, ProQR Therapeutics NV is projected to average $1.82, with a low of $1.58 and high of $2.08.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.